You are using an outdated browser. Please upgrade your browser to improve your experience.
Seizure Journal

Seizure - European Journal of Epilepsy

Seizure - European Journal of Epilepsy

Seizure Journal

by Elsevier Inc.
Seizure Journal
Seizure Journal
Seizure Journal

What is it about?

Seizure - European Journal of Epilepsy

Seizure Journal

App Details

Version
7.7.0
Rating
NA
Size
92Mb
Genre
Medical Magazines & Newspapers
Last updated
July 13, 2020
Release date
December 18, 2015
More info

App Screenshots

Seizure Journal screenshot-0
Seizure Journal screenshot-1
Seizure Journal screenshot-2
Seizure Journal screenshot-3
Seizure Journal screenshot-4

App Store Description

Seizure - European Journal of Epilepsy

Seizure - European Journal of Epilepsy app allows you to stay current on all topics related to epilepsy and seizure disorders, all with just a tap. Now available for both iPad and iPhone!
• Stay ahead with alerts when new issues are available and read Articles in Press throughout the month
• Experience innovative digital content with the newly introduced Article enhancements; featuring AudioSlides, Virtual Microscope, 3D Radiological Viewer, 3D Neuroimaging Viewer, and more.
• Get access to the journal content on the app via your institution’s IP
• Enjoy Open Access and Open Archive Content without having to login
• Accessibility support to assist the visually impaired
• Interact with figures, tables, and supplementary content
• Stream multimedia for faster viewing or download for later
• Take notes, highlight articles and share via email and social media
• Personalize your experience with My Reading List and save articles for offline reading
Minimum requirements: iOS 10
Journal subscribers: Log in with the same username and password obtained on the Seizure - European Journal of Epilepsy website that grants you access to the full journal content. These credentials will allow full access to all content on the app.

About Seizure - European Journal of Epilepsy

Seizure - European Journal of Epilepsy is an international journal owned by Epilepsy Action (the largest member led epilepsy organisation in the UK). It provides a forum for papers on all topics related to epilepsy and seizure disorders.

Seizure focuses especially on clinical and psychosocial aspects, but will publish papers on the basic sciences related to the condition itself, the differential diagnosis, natural history and epidemiology of seizures, as well as the investigation and practical management of seizure disorders (including drug treatment, neurosurgery and non-medical or behavioural treatments).

The journal reflects the social and psychological burden and impact of the condition on people with epilepsy, their families and society at large, and the methods and ideas that may help to alleviate the disability and stigma, which the condition may cause. The journal aims to share and disseminate knowledge between all disciplines that work in the field of epilepsy.

iTunes subscriptions to Seizure - European Journal of Epilepsy

A single issue of the journal for $64.99
1-year subscription to the journal for $599.99
Payment for all purchases will be charged to your iTunes account upon confirmation of purchase.

iTunes Subscriber’s Auto-Renew Feature
Yearly iTunes subscriptions will automatically renew each year unless you cancel. You can cancel at any time and up to 24 hours before your current subscription expires. Your iTunes account will automatically be charged the same price for the renewal within 24 hours prior to the end of the current period unless you change your subscription preferences in your iTunes Account Settings. You can manage your subscriptions through your Account Settings after purchase. No cancellation of the current subscription is allowed during the active subscription period.

Our privacy policy is here: http://www.elsevier.com/EULA_Apple_apps

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.